S.Korea's Celltrion, affiliates jump as chairman hints at merger
** South Korean drugmaker Celltrion 068270.KS and
affiliates jump after group chief hints at potential merger
** Celltrion Group Chairman Seo Jung-jin said "Celltrion and
its affiliates might be merged, if that's what shareholders
want" at a conference in the United States, according to company
spokesman
** Shares of Celltrion rise nearly 5% before trimming gains
to trade 1% higher, while Celltrion Pharm 068760.KQ and
Celltrion HealthCare 091990.KQ jump as much as 10.1% and 4%,
respectively
** The benchmark KOSPI index .KS11 up 0.2%, while the
junior KOSDAQ market .KQ11 0.4% higher
((Hayoung.Choi@thomsonreuters.com; +82 2 6936 1468))
Recent news on Celltrion Healthcare Co
See all newsBrief: Celltrion USA says Ventegra Will Place FDA-Approved Biosimilar To Avastin , Vegzelma On Its Commercial Formulary As A Preferred Brand
Brief: Celltrion Healthcare To Acquire 92.7 Billion Won Worth Of Own Shares
Brief: Celltrion Healthcare Q3 Operating Profit 50.5 Billion Won, Down 30.4% From Year Earlier
Brief: Celltrion Usa- Announces Distribution And Incorporation Of Yuflyma (Adalimumab-Aaty) To Carepartners Specialty Pharmacy Cost Savings Programs
Brief: Celltrion Healthcare's Merger With Celltrion Approved In Shareholder Meeting -Yonhap